Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece
- 156 Downloads
Normal autoimmune function is dependent on adequate levels of activated vitamin D, 25 hydroxy vitamin D [25(OH)D]. A recent study presented deficiency of 25(OH)D levels in Swedish MG patients. We aimed to study 25(OH)D levels in patients with MG and autoimmune polyneuropathies (PNP) at a southern latitude in Greece. Plasma levels of 25(OH)D were analyzed in Greek patients with MG (n = 19), immune-mediated PNP (N = 11) and in 30 Greek healthy age- and sex-matched controls. Ten MG patients received supplementation with vitamin D3. The MG Composite Score (MGC) and MG quality of life assessed disease severity in MG patients, whereas the INCAT Disability Scale assessed clinical features in the PNP patients. MG patients with and without vitamin D3 supplementation had higher 25(OH)D levels (mean 58.8 ± 16.3 and 62.0 ± 22.4 nmol/L, respectively) than PNP patients (mean 42.1 ± 11.5 nmol/L, p = 0.01) and healthy controls (mean 45.7 ± 13.8 nmol/L, p = 0.01). Plasma 25(OH)D levels was lower with age in all groups. There were no correlations between 25(OH)D and disease duration, MGC score, or INCAT score. Vitamin D deficiency was found in all Greek patient groups and healthy controls. Levels of 25(OH)D were higher in MG patients with as well as without vitamin D supplementation compared to healthy controls, whereas CIDP/GBS patients had levels similar to controls.
KeywordsMyasthenia gravis Guillain–Barré syndrome Vitamin D Autoimmune polyneuropathy
This work was supported by Lars Hiertas memorial foundation and Selanders foundation (ARP).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical and informed consent
All subjects signed written informed consent prior to inclusion into the study. The study protocol was approved by the Ethics Committee of PUH (No of approval: 37 /25-1-2012).
- 2.Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun Rev. 12:976–989CrossRefPubMedGoogle Scholar
- 3.Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70(9):1569–1574PubMedCentralCrossRefPubMedGoogle Scholar
- 8.Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML (2011) Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001–2006. J Clin Endocrinol Metab 96(12):3838–3845PubMedCentralCrossRefPubMedGoogle Scholar
- 12.Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55(1):16–23CrossRefPubMedGoogle Scholar
- 26.Becker W, Darnerud PO, Petersson-Grawe K (2007) Fiskkonsumtion-risk och nytta. National Food Adm, UppsalaGoogle Scholar